
Search our suppliers catalog
Leinco
Leinco

News about Leinco

Finding The Right Biomarker for Cancer Research
Cancer has a major impact on society around the world and biomarkers play a pivotal role in cancer research. Leinco technologies brings you numerous resources for validating biomarkers against different cancer types and stages, discovering new biomarkers to improve diagnostics and drug development, identifying the impact biomarkers have on disease progression, and more.
Take a look at the following list of cancer types to see the associated antibodies and proteins reported in applications.
Cancer Type | Related Antigens |
Lung Cancer | PD-L1, PD-1, CTLA-4 FAS/CD95, VEGF, EGFR |
Ovarian Cancer | PD-L1, PD-L2, HER-2, IGFBP-2 |
Breast Cancer | HER-2, EGFR, p53 |
Colorectal Cancer | VEGF, EGFR, IGFBP-2 |
Bladder Cancer | VEGF, Survivin/BIRC5, CCL18 |
Kidney Cancer | IL-6, VEGF, TRAIL |
Pancreatic Cancer | EGFR, IgG4, OPN, GDF-15 |
Osteosarcoma Cancer | CD47, Survivin, MMP |
Thyroid Cancer | MMP, Galectin-3 |
Leukemia Cancer | CTLA-4, CD52 |
Check the Cancer Biomarkers page for more details: Cancer Biomarkers page
Info Leinco
Manufacturer of In vivo Grade Bulk Antibodies
Leinco Technologies is a specialty manufacturer of early discovery research products including antibodies, recombinant proteins, ELISA kits, second step reagents and other life sciences products.
Leinco has developed proprietary methods for manufacturing In vivo functional grade antibodies with the highest purity standards in the industry. Their In vivo Platinum™ antibodies contain no preservatives or carrier proteins and have the most stringent quality specifications for purity (>98%), endotoxins (< 0.05 EU/mg), and aggregates.
For more information: Purified In vivo Grade Antibodies
Currently there are no products of the brand Leinco in our catalog.